Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was EGP 235.397 million compared to EGP 235.103 million a year ago. Operating income was EGP 45.974 million compared to EGP 46.712 million a year ago. Net income was EGP 24.900 million compared to EGP 10.650 million a year ago. Basic earnings per share was EGP 0.0324 compared to EGP 0.014 a year ago. For the nine months, sales was EGP 672.858 million compared to EGP 619.459 million a year ago. Operating income was EGP 124.381 million compared to EGP 132.080 million a year ago. Net income was EGP 68.666 million compared to EGP 31.612 million a year ago. Basic earnings per share was EGP 0.0893 compared to EGP 0.0411 a year ago.